Wednesday, February 1, 2017
Charles River Associates (CRA), a provider of economic, financial, and management consulting services, has acquired substantially all of the assets of C1 Consulting, a life sciences strategy consulting firm that helps pharmaceutical and biotech clients maximize their business potential through the development of highly tailored commercialization strategies based on advanced analytics, customer insights and therapy area expertise. The newly acquired team will join CRA’s Life Sciences Practice and provide additional breadth, depth, and scale to CRA’s client offerings across the industry. Financial terms of the acquisition were not disclosed. CRA expects the acquisition to be accretive to earnings in fiscal 2017.